A cure worse than the disease • Inside Story

Back in March, just two months into Donald Trump’s second presidential term, I wrote about the possible impact of Trump’s policies on Australia’s Pharmaceutical Benefits Scheme, or PBS. Despite heavy lobbying from the US industry group PhRMA, the many threats…